The health consequences are also becoming harder to ignore: Several doctors told Business Insider in July that they've seen a sharp increase in patients on GLP-1 medications when they enter treatment for eating disorders
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone to reduce appetite, slow gastric emptying, and improve blood sugar control, leading to reduced calorie intake and sustained weight loss
Still, live-birth data remain sparse, and heterogeneity in PCOS phenotype, baseline OS, and stimulation protocols complicates pooled inference
Crohns disease, should be excluded
McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ (2021) Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation
du Plessis SS, Agarwal A, Syriac A